GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sphere Medical Holding PLC (LSE:SPHR) » Definitions » Net Current Asset Value

Sphere Medical Holding (LSE:SPHR) Net Current Asset Value : £0.02 (As of Dec. 2016)


View and export this data going back to 2011. Start your Free Trial

What is Sphere Medical Holding Net Current Asset Value?

In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).

Sphere Medical Holding's net current asset value per share for the quarter that ended in Dec. 2016 was £0.02.

The historical rank and industry rank for Sphere Medical Holding's Net Current Asset Value or its related term are showing as below:

During the past 9 years, the highest Price-to-Net-Current-Asset-Value Ratio of Sphere Medical Holding was 5.75. The lowest was 0.50. And the median was 3.18.

LSE:SPHR's Price-to-Net-Current-Asset-Value is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 4.765
* Ranked among companies with meaningful Price-to-Net-Current-Asset-Value only.

Sphere Medical Holding Net Current Asset Value Historical Data

The historical data trend for Sphere Medical Holding's Net Current Asset Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sphere Medical Holding Net Current Asset Value Chart

Sphere Medical Holding Annual Data
Trend Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
Net Current Asset Value
Get a 7-Day Free Trial Premium Member Only 0.12 0.14 0.06 0.07 0.02

Sphere Medical Holding Semi-Annual Data
Dec11 Jun12 Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16
Net Current Asset Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.06 0.09 0.07 0.05 0.02

Competitive Comparison of Sphere Medical Holding's Net Current Asset Value

For the Medical Devices subindustry, Sphere Medical Holding's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sphere Medical Holding's Price-to-Net-Current-Asset-Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sphere Medical Holding's Price-to-Net-Current-Asset-Value distribution charts can be found below:

* The bar in red indicates where Sphere Medical Holding's Price-to-Net-Current-Asset-Value falls into.



Sphere Medical Holding Net Current Asset Value Calculation

Sphere Medical Holding's Net Current Asset Value (NCAV) per share for the fiscal year that ended in Dec. 2016 is calculated as

Net Current Asset Value Per Share(A: Dec. 2016 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(3.849-0.757-0-0)/141.76
=0.02

Sphere Medical Holding's Net Current Asset Value (NCAV) per share for the quarter that ended in Dec. 2016 is calculated as

Net Current Asset Value Per Share(Q: Dec. 2016 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(3.849-0.757-0-0)/141.76
=0.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sphere Medical Holding  (LSE:SPHR) Net Current Asset Value Explanation

Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."

The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]

Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.

One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham’s strategy produced similar results.

Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.


Sphere Medical Holding Net Current Asset Value Related Terms

Thank you for viewing the detailed overview of Sphere Medical Holding's Net Current Asset Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Sphere Medical Holding (LSE:SPHR) Business Description

Traded in Other Exchanges
N/A
Address
Harston Mill, Harston, Cambridge, GBR, CB22 7GG
Sphere Medical Holding Ltd is a UK-based company which is engaged in research and development, manufacturing and sale of medical monitoring and diagnostic equipment within the medical device area. It focuses on developing the Proxima platform for measuring blood gases, electrolytes and metabolites. Proxima is an in-line patient dedicated arterial blood analyser which supports frequent measurements at critical times. It markets its product (Proxima) to critical care market which includes ICU (Intensive Care Unit) and OR (Operating Room). The company's products are used in medical applications, enabling faster clinical decision-making and improved patient outcomes. It operates is business in single reporting segment of Medical devices. Most of the company's revenue comes from Europe.